Speaker(s): 

Lindsey Kisielewski, PharmD, Resident I Pharmacy – Pharmacy Resident Program, Geisinger Wyoming Valley, Wilkes Barre PA - has nothing to disclose.

Anye Stevenson, PharmD, Resident I Pharmacy – Pharmacy Resident Program, Geisinger Wyoming Valley, Wilkes Barre PA - has nothing to disclose.

Moderator(s): 

Adriene K. Zook, PharmD, RPH, Manager Pharmacy, Geisinger Medication Therapy Disease Management, Danville PA - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Summarize the updates regarding pharmacotherapy in the 2025 American Diabetes Association Standards of Care.

• Discuss how these updates impact clinical decision making for diabetes management.

• Evaluate changes for pharmacological recommendations regarding special populations. 

• Review updated recommendations regarding the use of diabetes technology. 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stacy Coolbaugh, MBA, RDN, LDN; Angela Esherick, RDN, LDN, CDCES; Adriene Zook, PharmD, RPH; Dan Huston, DNP, RN and Joey Underhill have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None